GleamWall
中文EN

WOK WORK Medical Technology Group LTD Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1929783 · Fiscal year ends 09/30

Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-14.4%
TTM net income YoY69.3%
TTM EPS YoY85.2%
Revenue 3-yr CAGR-20.6%
Net income 3-yr CAGR—

Margins

Gross margin23.8%
Operating margin—
Net margin-10.9%
FCF margin49.9%
EBITDA margin—

Returns

ROE-6.8%
ROA-3.1%
ROIC (approx.)—
Asset turnover0.28x

Leverage & solvency

Liabilities / assets36.2%
Debt / equity0.00x
Current ratio1.71x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-5.82x
Accruals ratio-21.1%
Payout ratio—
Capex / revenue13.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue$9.85M$11.51M
Gross profit$2.34M$2.87M
R&D expense$435,311$302,511
SG&A expense$2.33M$4.56M
Interest expense$503,519$557,571
Pretax income-$1.08M-$3.67M
Income tax$119,053-$125,291
Net income-$1.07M-$3.49M
EPS (basic)-0.04-0.27
EPS (diluted)-0.04-0.27
Weighted avg. shares (diluted)28.98M12.71M
Balance sheet
Cash & equivalents$4.09M$6.56M
Receivables$615,838$1.65M
Inventory$2.46M$3.18M
Current assets$20.46M$20.83M
PP&E, net$10.59M$11.37M
Intangibles$959,116$1.04M
Total assets$33.16M$36.25M
Current liabilities$11.97M$20.18M
Short-term debt$6.39M$13.32M
Total liabilities$11.99M$20.18M
Shareholders' equity$18.34M$13.19M
Shares outstanding—14.59M
Cash flow statement
Operating cash flow$6.24M-$2.23M
Capital expenditure$1.33M$9.23M
Free cash flow$4.91M-$11.45M
Investing cash flow-$7.61M-$9.06M
Financing cash flow-$898,212$15.66M
Depreciation & amortization$923,108$1.41M

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.